Clinical Trial Update: A Longitudinal Evaluation of a Radiotracer for Use in Tau Tracking [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a radiotracer for tau tracking in Alzheimer disease and mild cognitive impairment; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Alzheimer Disease, Mild Cognitive Impairment | Phase 2 | Status: COMPLETED | Results posted: 2023-08-03